Mesoporous Silica Provides a Platform for Robust Amplification of Single-Copy RNA

Area of Science:

• Biotechnology
• Nanotechnology
• Molecular Biology

Background:

• Accurate diagnosis of COVID-19 relies on detecting SARS-CoV-2 RNA.
• Conventional RT-PCR often lacks sensitivity, leading to false-negatives for low viral loads.
• Developing ultrasensitive amplification is critical for early disease detection.

Purpose of the Study:

• To establish an ultrasensitive amplification technology for SARS-CoV-2 RNA analysis.
• To overcome the sensitivity limitations of conventional RT-PCR methods.
• To enhance early diagnosis of COVID-19.

Main Methods:

• Immobilizing DNA polymerase into mesoporous silica nanopores.
• Optimizing silica pore structure for selective and efficient amplification.
• Testing the DNA polymerase-mesoporous silica composite's performance with single-copy RNA, background DNA, and PCR inhibitors.

Main Results:

• Achieved ultrasensitive amplification of SARS-CoV-2 RNA from single-copy targets.
• Demonstrated high selectivity and efficiency, even with nontarget DNA present.
• Showed improved resistance to PCR inhibitors and robust long-term stability without conventional enzyme stabilizers.

Conclusions:

• Mesoporous silica provides a sensitive and reliable platform for analyzing minimal amounts of RNA.
• The developed composite enhances RT-PCR sensitivity and robustness for diagnostics.
• This technology holds promise for early detection and reliable analysis of RNA targets.